Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression.

Bourguignon LY.

Semin Cancer Biol. 2008 Aug;18(4):251-9. doi: 10.1016/j.semcancer.2008.03.007. Epub 2008 Mar 26. Review.

2.

Cancer statistics, 2008.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ.

CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.

3.

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, Viroglio Rdel C, Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris CM Jr, Haddad RI; TAX 324 Study Group.

N Engl J Med. 2007 Oct 25;357(17):1705-15.

4.

Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death.

Yu HG, Ai YW, Yu LL, Zhou XD, Liu J, Li JH, Xu XM, Liu S, Chen J, Liu F, Qi YL, Deng Q, Cao J, Liu SQ, Luo HS, Yu JP.

Int J Cancer. 2008 Jan 15;122(2):433-43.

5.

Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer.

Furuya F, Lu C, Willingham MC, Cheng SY.

Carcinogenesis. 2007 Dec;28(12):2451-8. Epub 2007 Jul 28.

PMID:
17660507
6.

The influence of hyaluronan-CD44 interaction on topoisomerase II activity and etoposide cytotoxicity in head and neck cancer.

Wang SJ, Peyrollier K, Bourguignon LY.

Arch Otolaryngol Head Neck Surg. 2007 Mar;133(3):281-8.

PMID:
17372087
7.

The role of CD44 in HNSCC.

Nelson AD, Grandis JR.

Cancer Biol Ther. 2007 Jan;6(1):125-6. No abstract available.

PMID:
17297303
9.
10.

RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo.

Faried A, Faried LS, Kimura H, Nakajima M, Sohda M, Miyazaki T, Kato H, Usman N, Kuwano H.

Eur J Cancer. 2006 Jul;42(10):1455-65. Epub 2006 Jun 5.

PMID:
16750623
12.
13.

Hyaluronan-CD44 promotes phospholipase C-mediated Ca2+ signaling and cisplatin resistance in head and neck cancer.

Wang SJ, Bourguignon LY.

Arch Otolaryngol Head Neck Surg. 2006 Jan;132(1):19-24.

PMID:
16415424
14.

Global cancer statistics, 2002.

Parkin DM, Bray F, Ferlay J, Pisani P.

CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108.

15.

Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.

de Vicente JC, Fresno MF, Villalain L, Vega JA, Hernández Vallejo G.

Oral Oncol. 2005 Mar;41(3):283-93.

PMID:
15743691
16.

AKT involvement in cisplatin chemoresistance of human uterine cancer cells.

Gagnon V, Mathieu I, Sexton E, Leblanc K, Asselin E.

Gynecol Oncol. 2004 Sep;94(3):785-95.

PMID:
15350374
17.

Signaling pathways required for matrix metalloproteinase-9 induction by betacellulin in head-and-neck squamous carcinoma cells.

O-charoenrat P, Wongkajornsilp A, Rhys-Evans PH, Eccles SA.

Int J Cancer. 2004 Aug 20;111(2):174-83.

20.

Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth.

Bourguignon LY, Zhu H, Zhou B, Diedrich F, Singleton PA, Hung MC.

J Biol Chem. 2001 Dec 28;276(52):48679-92. Epub 2001 Oct 17.

Supplemental Content

Support Center